Nbs1-dependent binding of Mre11 to adenovirus E4 mutant viral DNA is important for inhibiting DNA replication  by Mathew, Shomita S. & Bridge, Eileen
Available online at www.sciencedirect.com
08) 11–22
www.elsevier.com/locate/yviroVirology 374 (20Nbs1-dependent binding of Mre11 to adenovirus E4 mutant viral DNA is
important for inhibiting DNA replication
Shomita S. Mathew 1, Eileen Bridge ⁎
Department of Microbiology, 32 Pearson Hall, Miami University, Oxford OH 45056, USA
Received 13 July 2007; returned to author for revision 30 August 2007; accepted 14 December 2007
Available online 29 January 2008
Abstract
Adenovirus (Ad) infections stimulate the activation of cellular DNA damage response and repair pathways. Ad early regulatory proteins
prevent activation of DNA damage responses by targeting the MRN complex, composed of the Mre11, Rad50 and Nbs1 proteins, for
relocalization and degradation. In the absence of these viral proteins, Mre11 colocalizes with viral DNA replication foci. Mre11 foci formation at
DNA damage induced by ionizing radiation depends on the Nbs1 component of the MRN complex and is stabilized by the mediator of DNA
damage checkpoint protein 1 (Mdc1). We find that Nbs1 is required for Mre11 localization at DNA replication foci in Ad E4 mutant infections.
Mre11 is important for Mdc1 foci formation in infected cells, consistent with its role as a sensor of DNA damage. Chromatin immunoprecipitation
assays indicate that both Mre11 and Mdc1 are physically bound to viral DNA, which could account for their localization in viral DNA containing
foci. Efficient binding of Mre11 to E4 mutant DNA depends on the presence of Nbs1, and is correlated with a significant E4 mutant DNA
replication defect. Our results are consistent with a model in which physical interaction of Mre11 with viral DNA is mediated by Nbs1, and
interferes with viral DNA replication.
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Adenovirus (Ad) has a 36 kbp linear double stranded (ds)
DNA genome. Ad infection can potentially trigger DNA damage
response cascades that interfere with a productive infectious
program (reviewed by Weitzman and Ornelles, 2005). Cellular
DNA damage response pathways maintain the genetic integrity
and survival of the cell. The surveillance and signal amplifica-
tion processes induced in response to double strand breaks
(DSB), activate DNA repair and cell cycle checkpoint proteins.
Ataxia telangiectasia mutated (ATM), AT- and Rad3-related
(ATR) and DNA protein kinase (DNA PK) are serine–threonine
kinases that are activated in response to unique damage signals.
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DNA, while DNA PK mediates signaling responses that recruit
the Ligase IV/Xrcc4 complex to mediate ligation of DSBs in
non-homologous end joining (NHEJ) (Shiloh, 2003). The ATM
pathway is primarily induced by DNA DSBs and is character-
ized by the phosphorylation and activation of numerous cellular
proteins such as the modified histone protein H2AX, mediator of
DNA damage checkpoint protein 1 (Mdc1), Nijmegen break
syndrome protein (Nbs1), Breast cancer 1 (BRCA1), the tumor
suppressor p53, and checkpoint protein 2 (Chk2) among others,
that regulate the cell-cycle checkpoints and DNA repair path-
ways (Shiloh, 2003). Mdc1 is implicated in the amplification of
ATM-dependent DNA damage signals. It is thought to be in-
volved in the accumulation of activated ATM and its various
substrates at or near DSBs to facilitate their phosphorylation and
regulate the damage response (Lou et al., 2006).
The precise mechanism used to sense a DNA damage event
and signal a response is still an active area of research. However,
there is substantial evidence that the MRN complex, composed
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sensing and activation of ATM. The MRN complex is evolu-
tionarily conserved from yeast to mammals and is involved in
homologous recombination, cell-cycle checkpoint regulation
and meiotic recombination (Sharples and Leach, 1995; Dolga-
nov et al., 1996; Petrini et al., 1995; Carney et al., 1998). In
response to DSBs, MRN complex proteins are some of the
earliest proteins associated with the site of DNA damage
(Celeste et al., 2003; Lisby et al., 2004). The Mre11/Rad50
heterodimer binds to the ends of the DNA break and Mre11 has
nuclease activity that resects the ends to expose regions of
microhomology that are important for ligation and repair
(Trujillo et al., 1998; Paull and Gellert, 1998). Rad50 tethers
the DNA ends together via interactions between its coiled coil
domains (Hopfner et al., 2002). Rad50 binds ATP and provides
the energy required for the nuclease activity of Mre11 (Paull and
Gellert, 2000). The Nbs1 component is essential for recruitment
and accumulation of the complex at the site of damage (Falck
et al., 2005; Cerosaletti et al., 2006), and the effective activation
of ATM in response to damage (Uziel et al., 2003; Carson et al.,
2003). Each of these proteins is therefore important for the
proper functioning of theMRN complex in the damage signaling
and response pathway.
Accumulation of the damage response proteins in foci is a
dynamic process and a useful marker to analyze the cellular
response to DSBs (Lisby et al., 2004). Foci are formed at DSBs,
sites of replication stress, regions of ssDNA, and shortened
telomeres (Raderschall et al., 1995; Lisby et al., 2003; D'Adda
di Fagagna et al., 2003). It is speculated that accumulation of
proteins in foci facilitates the concentration of repair proteins
specifically at the lesion. Efficient rejoining of the DSB is then
promoted by the relatively high concentration of repair factors
in the vicinity of DNA ends within the foci (reviewed by Lisby
and Rothstein, 2004).
Ad E4 mutant infections trigger the ATM and ATR damage
response cascades (Carson et al., 2003). The products of Ad E4
open reading frame (ORF) 3 (E4-11kDa) and E4 ORF 6 (E4-
34kDa) along with the E1b-55kDa protein, target the MRN
complex for relocalization and proteasome mediated degrada-
tion, and in so doing effectively inhibit the cellular damage
response. In the absence of E4 proteins, the MRN complex
accumulates in foci corresponding to viral DNA replication
foci, promotes viral genome concatenation, and inhibits viral
DNA replication and late gene expression (Stracker et al., 2002;
Jayaram and Bridge, 2005; Evans and Hearing, 2005; Mathew
and Bridge, 2007). Removal of the Mre11 protein by RNAi
(Mathew and Bridge, 2007) or infection of cells that lack Mre11
(ATLD) (Evans and Hearing, 2005), rescues the E4 mutant
replication defect, indicating that Mre11 is able to interfere with
a productive infection if it is not inactivated by E4 proteins.
Here we have tested the hypothesis that the mechanism of
Mre11 interference in E4 mutant DNA replication is a con-
sequence of its physical interaction with viral genomes. We
show that Mre11 is physically bound to E4 mutant viral DNA
and this depends on the presence of Nbs1. Interfering with
Mre11 binding to viral DNA alleviates the E4 mutant DNA
replication defect. We also find that Mre11 is important for earlyMdc1 foci formation in response to E4 mutant infection, con-
sistent with its role as a sensor of DNA damage events.
Results
Mre11 localizes to E2-72kDa containing viral replication foci
in E4 mutant infection, and it binds to E4 mutant viral DNA
E4 mutant H5dl1007 carries a deletion that disrupts all of the
E4 ORFs (Bridge and Ketner, 1989), and therefore fails to
prevent activation of a DNA damage response and genome
concatenation in infected cells (Carson et al., 2003; Jayaram and
Bridge, 2005). Mre11 co-localizes with the viral E2-72kDa
DNA binding protein (DBP) at E4 mutant DNA replication
centers (Stracker et al., 2002). We have examined the distri-
bution of Mre11 in a time course infection with H5dl1007 to
further understand the dynamics of the association of Mre11
with DNA replication centers. Initially we see that Mre11 is
tightly associated with viral E2-72kDa in the replication foci
that start to form early in the infection process (6–12 h post
infection (hpi), Fig. 1B, panels a to f). As the replication centers
develop, Mre11 localizes preferentially to the periphery of the
E2-72kDa centers at later stages (18–24 hpi, Fig. 1B, panels g
to l). The tight association of Mre11 with the E2-72kDa centers
early in the infection process suggests that Mre11 might directly
or indirectly bind viral DNA in these centers. Mre11 is a
member of the MRN complex together with Rad50 and Nbs1,
and has DNA binding domains that are likely to be important for
its role in DNA repair events. We were therefore interested in
investigating the possibility that Mre11 was physically bound to
E4 mutant viral DNA and the dynamics of this binding over
time. We performed chromatin immunoprecipitation (chIP)
experiments on samples prepared from HeLa cells infected with
the E4 mutant H5dl1007 for 12 and 24 h to measure binding to
viral DNA at intermediate and late times after infection. Pull
down of Mre11 using specific antibody (Ab) was confirmed
by Western blotting. As expected, immunoprecipitation with
Mre11 Ab pulled down the ∼80 kDa protein corresponding to
Mre11 in uninfected and E4 mutant infected samples (Fig. 1C,
top panel). We performed immunoprecipitation with viral E2-
72kDa DNA binding protein and Ab against phosphoinositol-3-
kinase (PI3K) as positive and negative controls for the chIP
experiments, respectively. These antibodies pulled down the
expected proteins in immunoprecipitation experiments as
expected (Fig. 1C). We next performed PCR experiments on
chromatin samples immunoprecipitated with Abs against
Mre11, E2-72kDa, or PI3K from formaldehyde fixed cells.
Viral DNAwas amplified with primers specific for the Ad E1b
region. We see a PCR amplified signal only in E4 mutant
infected samples immunoprecipitated with either E2-72kDa Ab
or Mre11 Ab at 12 hpi (Fig. 1D). No PCR product was observed
in cells that were precipitated with PI3K antibody demonstrat-
ing the specificity of Mre11 binding to E4 mutant DNA. We
also did not detect viral DNA in samples that were mock
immunoprecipitated without the addition of Ab. Binding of
Mre11 to E4 mutant DNAwas not detected at 24 hpi (Fig. 1D).
We have performed similar experiments in Ad5 infected cells
Fig. 1. Mre11 localizes to E2-72kDa containing viral replication foci in E4 mutant infection and it is bound to E4 mutant DNA. HeLa cells were uninfected (UI) or
infected with H5dl1007 (1007) at 30 FFU/cell for the times indicated. (A and B) Immunofluorescence staining was performed with antibodies specific for Mre11
(A, panel a; B, panels a, d, g, and j) and the viral E2-72kDa protein (A, panel b; B, panels b, e, h, and k). Bar 10 μm. Uninfected cells and cells infected for 12 or 24 h
with H5dl1007 were treated with formaldehyde and used for chIP experiments as described in Materials and methods. (C) Western blotting was performed to confirm
immunoprecipitation of Mre11, E2-72kDa and PI3K with their respective antibodies; representative blots are shown. Lanes from samples that were
immunoprecipitated with specific Ab or mock immunoprecipitated are labeled (+) and (−), respectively. (D) PCR amplification using primers specific to the E1b
region was performed on chromatin samples prepared from uninfected and H5dl1007 infected cells that were immunoprecipitated (+) with Mre11, PI3K, or E2-72kDa
Abs as indicated, or mock immunoprecipitated in parallel without the addition of Ab (−). PCR reactions were fractionated on a 1% agarose gel and stained with
ethidium bromide to visualize the 400 bp expected PCR product. Total input chromatin (TIC) samples prepared from UI (TIC1) and H5dl1007 infected cells (TIC2)
were included to indicate input DNA levels. ChIP experiments with the Mre11 and E2-72kDa antibodies were performed 3 times with similar results. ChIP
experiments with Mre11 and PI3K antibodies were performed twice with similar results.
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or 24 hpi (data not shown), consistent with the ability of Ad5 to
degrade the Mre11 protein in infected cells. E2-72kDa binds to
Ad5 DNA at both 12 and 24 hpi (data not shown) as expected.
Our UI samples were devoid of any signal as expected. The total
input chromatin (TIC) samples were included to show input
levels of DNA from UI (TIC1) and E4 mutant infected cells
(TIC2). Our results indicate that Mre11 is specifically bound to
E4 mutant DNA at 12 hpi.
Rad50 and Nbs1 are important for Mre11 localization to viral
DNA replication centers and inhibition of E4 mutant viral DNA
replication
TheMRNcomplex is made up of theMre11, Rad50 andNbs1
proteins. The entire complex associates with E4 mutant DNA
replication centers and is important for concatenation of viral
genomes. However, the role of each member of this complex in
E4 mutant infection is not yet clearly understood. We havepreviously used RNAi mediated knockdown to show that Mre11
interferes with E4 mutant DNA replication (Mathew and Bridge,
2007). We performed siRNA knockdown experiments to target
Rad50 and Nbs1 using a pool of 4 duplexes to target each
respective mRNA (see Materials and methods) and monitored
the effect on Mre11 distribution and E4 mutant DNA replication
using immunofluorescence (IF) and Southern blotting experi-
ments, respectively. The results are shown in Figs. 2 and 3. First
we performed Western blotting experiments to confirm specific
knockdown of the targeted proteins (Figs. 2A and 3A). Trans-
fection with Rad50 or Nbs1 siRNAs specifically knocked down
expression of the respective protein in HeLa cells. The level of
either Rad50 or Nbs1 was unaffected in cells treated with non-
specific siRNA (non-targeting scrambled siRNA), control
siRNA against glyceraldehyde-3-phosphate dehydrogenase
(GAPD) or lipofection reagent D1.
Rad50 is distributed in foci that contain Mre11 in H5dl1007
infected, untreated cells (Fig. 2B, panels g and h). When we
knock down Rad50 with its specific siRNA, levels of Mre11 are
Fig. 2. Rad50 is important for Mre11 stability and the inhibition of E4 mutant DNA replication. HeLa cells were transfected with control siRNA or Rad50 siRNA prior
to infection with Ad5 or H5dl1007 at 3 FFU/cell for 24 h. (A) Rad50 knockdown was monitored byWestern blotting of 75 μg of total protein prepared 96 h after mock
(−) or Rad50 specific siRNA (+) transfection, using rabbit polyclonal Ab against Rad50. Additional controls demonstrating the specificity of Rad50 expression
knockdown included no treatment (UT), non-targeting siRNA (non-targeting), siRNA against GAPD, and treatment with the transfection reagent alone (D1).
(B) Mre11 and Rad50 distribution in untransfected uninfected (panels a to c) and cells infected with H5dl1007 (panels g to i) for 24 hpi are shown. The distribution of
Mre11 and Rad50 in siRNA transfected HeLa cells that were either uninfected or infected for 24 h with H5dl1007 are shown in panels d to f and j to l respectively. A
Western blot depicting levels of Mre11 in Rad50 siRNA treated cells is also shown (right panel). (C) Panels a to f show the distribution of host Mre11 and viral E2-
72kDa in uninfected and H5dl1007 infected cells in the absence of siRNA transfection. Panels g to l show the distribution of Mre11 and E2-72kDa in cells transfected
with Rad50 siRNA that were subsequently uninfected or infected with H5dl1007. Bar 10 μm. (D) Levels of viral DNA synthesis in Ad5 and H5dl1007 infected HeLa
with (+) and without (−) Rad50 siRNA transfection were quantified by Southern analysis of 10 μg of Eco RI digested total DNA prepared at 24 hpi. The Eco R1 C
fragment from the DNA digestion was used for comparison between Ad5 and H5dl1007.
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compare panels a and g with d and j) and Western blotting
(Fig. 2B, right panel). Phosphorimager quantitation indicated at
least a 3-fold reduction in levels of the Mre11 protein in Rad50
siRNA treated cells, indicating that Rad50 is important for
stabilizing the Mre11 protein. The E4 mutant replication centers
that form in Rad50 siRNA treated cells are larger and more
numerous than those in the untreated HeLa cells (Fig. 2C,
compare panels e and k). The level of E4 mutant DNA
replication was measured by Southern blotting experiments
(Fig. 2D). In HeLa cells that have not been transfected with
Rad50 siRNA, E4 mutant DNA replication is severely defective
compared to wild-type Ad5 (50–70 fold). However in HeLa
cells knocked down for Rad50, the DNA replication defect issignificantly rescued (to within 2-fold of Ad5), as evidenced by
the relative increase in levels of E4 mutant DNA. Our results
indicate that knockdown of Rad50 moderates the E4 mutant
DNA replication defect. However, this could be due to a
secondary effect on the stability of Mre11, rather than a direct
effect of Rad50 knockdown.
Nbs1 is distributed in foci containing Mre11 in E4 mutant
infected, untransfected cells (Fig. 3A, panels g and h). RNAi
knockdown of Nbs1 dramatically affects the distribution of
Mre11 within the cell. In the presence of Nbs1, Mre11 is
primarily in the nucleus. However, knockdown of Nbs1 mis-
localizes Mre11 to the cytoplasm (Fig. 3A, panels j and k). This
is an expected result because the Nbs1 protein provides a nuclear
localization signal (NLS) that is required for the translocation of
Fig. 3. Nbs1 is important for Mre11 localization and the inhibition of E4 mutant DNA replication. HeLa cells were transfected with control siRNA or Nbs1 siRNA
prior to infection with Ad5 or H5dl1007 at 3 FFU/cell for 24 h. (A) Nbs1 knockdown was monitored by Western blotting using 75 μg of total protein prepared 96 h
after mock (−) or Nbs1 specific siRNA (+) transfection, using goat polyclonal Ab against Mre11. Additional controls demonstrating the specificity of Nbs1
expression knockdown included no treatment (UT), non-targeting siRNA (non-targeting), siRNA against GAPD, and treatment with the transfection reagent alone
(D1). Mre11 and Nbs1 distribution in untransfected, uninfected cells (panels a to c) and cells infected with H5dl1007 (panels g to i) for 24 h are shown. The
distribution of Mre11 and Nbs1 in siRNA transfected HeLa cells that were either uninfected or infected for 24 h with H5dl1007 are shown in panels d to f and j to l
respectively. (B) Mre11 and viral E2-72kDa protein distribution in untransfected cells that were either uninfected (panels a–c) or infected (panels g to I) are shown.
The distribution of Mre11 and E2-72kDa distribution in Nbs1 siRNA transfected cells that were either uninfected or infected with H5dl1007 is shown in panels d to f
and j to l, respectively. Bar 10 μm. (C) Levels of viral DNA synthesis in Ad5 and H5dl1007 infected HeLa with (+) and without (−) Nbs1 siRNA transfection were
quantified by Southern analysis of 10 μg of EcoRI digested total DNA prepared at 24 hpi. The C fragment from the DNA digestion was used to compare Ad5 and
H5dl1007 DNA levels.
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vestigated the effect of this mis-localization on E4 mutant DNA
replication by IF. E4 mutant replication centers were generally
larger in cells treated with Nbs1 siRNA when compared to
untreated cells (Fig. 3B, compare panel h with k). We further
investigated the effect of Nbs1 knockdown and Mre11 mis-
localization on E4mutant DNA replication, by Southern blotting
experiments. Our results are shown in Fig. 3C. In the cells that
were not transfected with Nbs1 siRNA, levels of E4 mutant
DNA are significantly lower than that of Ad5 (50- to 70-fold).
However, knock down of Nbs1 by siRNA dramatically increases
the level of E4 mutant DNA which is now similar to wild type
Ad5 (within 2-fold). These results show that knocking down
Nbs1 rescues the E4 mutant DNA replication defect; this could
be due to mis-localization of Mre11 in the cytoplasm, and/or to a
more direct role of Nbs1 in interfering with E4 mutant DNA
replication.Nuclear Mre11 is unable to localize to E4 mutant replication
centers and does not bind viral DNA in the absence of Nbs1
Mre11 requires the Nbs1 protein for translocation into the
nucleus. Nbs1 is also important for the localization of Mre11 in
foci in response to DNA damage induced by ionizing radiation
(IR) (Cerosaletti et al., 2006). We were interested in investigat-
ing the role of Nbs1 in the accumulation of nuclear Mre11 at E4
mutant DNA replication foci. For this purpose we obtained cells
lacking Nbs1 (NBS-ILB1 LXIN), and cells that lack Nbs1 but
stably express Mre11 engineered with an exogenous nuclear
localization signal to direct it to the nucleus independently of
Nbs1 (NBS-ILB1 NLS.12, hereafter referred to as NLS.12)
from Drs. Cerosaletti and Concannon. Cerosaletti et al. (2006)
have shown that the Mre11-NLS protein produced in NLS.12
cells interacts with Rad50 and is able to activate ATM-
dependent damage responses when introduced into ATLD cells
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NLS is functional. We used this experimental system to deter-
mine if Nbs1 is important for the formation of Mre11 foci in E4
mutant infections. NBS-ILB1 LXIN, NLS.12, and HeLa cells
were infected with Ad5 or E4 mutant H5dl1007. The ability of
Mre11 to localize in viral DNA replication centers was assessed
by IF and binding to viral DNA was measured in chIP exper-
iments. Our results are represented in Fig. 4. We see that in
HeLa cells (Fig. 4A, panels a to i), infection with H5dl1007
causes the formation of Mre11 foci that co-localize with the
viral E2-72kDa foci. In dramatic contrast, infection of NLS.12
cells (Fig. 4A, panels j to r) shows a clear inhibition of Mre11
foci formation, although Mre11 is detected in the nucleus in
these cells as expected. Immunofluorescence experiments
confirmed that Rad50 was also localized in the nucleus in
uninfected and E4 mutant infected NLS.12 cells (data not
shown). In late phase infected NLS.12 cells, Mre11 surrounds
but is still excluded from viral E2-72kDa-containing centers
(compare panels p and q). The confocal overlay (panel r) shows
no overlap of the red and green staining patterns. E4 mutantFig. 4. Nbs1 is important for Mre11 localization in E4 mutant replication centers an
H5dl1007 for 10 h (early) and 24 h (late) at 3 FFU/cell. Confocal microscopy was us
72kDa (panels b, e, h, k, n, q) proteins in uninfected and infected cells. Merged images
were performed as described in Fig. 1 using samples prepared from NLS.12 cells that
blotting was performed to confirm immunoprecipitation of Mre11 and E2-72kDa fro
preparation for chIP analysis. Lanes from samples that were immunoprecipitated wit
(C) PCR amplification using primers specific to the E1b region was performed on UI
Mre11 or E2-72kDa. PCR products were analyzed as described in Fig. 1. Lan
immunoprecipitated in parallel are labeled (+) and (−), respectively. Total input chrom
included to indicate input DNA levels. The chIP experiments were performed twice w
infected with Ad5 and H5dl1007 at 3 FFU/cell were quantified by Southern analysis
the DNA digestion was used for comparison between Ad5 and H5dl1007.infected NBS-ILB1 LXIN cells, which have Mre11 mis-
localized in the cytoplasm, also do not show Mre11 foci
formation (data not shown). We subsequently performed chIP
experiments on NLS.12 cells as described for Fig. 1 to analyze
the DNA binding capacity of nuclear Mre11 in the absence of
Nbs1. Immunoprecipitation controls are shown in Fig. 4B and
indicate that antibodies against Mre11 and E2-72kDa pull down
the expected proteins. We show in Fig. 4C that the absence of
Nbs1 alters the DNA binding capacity of Mre11 as evidenced
by the absence of a specific PCR amplified signal in chromatin
immunoprecipitated from E4 mutant infected samples with
Mre11 Ab. Our uninfected controls are devoid of any signal as
expected (Fig. 4C), we also saw no PCR product in samples that
were precipitated with PI3K Ab (data not shown). The positive
control experiments in which chromatin from E4 mutant
infected samples was immunoprecipitated with the viral E2-
72kDa Ab showed a specific PCR product (Fig. 4C). Our results
indicate that in E4 mutant infections, efficient binding of Mre11
to viral DNA and localization at replication centers requires the
Nbs1 protein.d Mre11 binding to viral DNA. (A) HeLa and NLS.12 cells were infected with
ed to analyze the distribution of host Mre11 (panels a, d, g, j, m, p) and viral E2-
of these staining patterns are shown in panels c, f, i, and l, o, r. ChIP experiments
were uninfected or infected with H5dl1007 for 12 h at 30 FFU/cell. (B) Western
m chromatin prepared from H5dl1007 infected and uninfected NLS.12 cells, in
h specific Ab or mock immunoprecipitated are labeled (+) and (−), respectively.
and H5dl1007 infected samples prepared at 12 hpi and immunoprecipitated with
es from samples that were immunoprecipitated with specific Ab or mock
atin samples from uninfected (TIC1) and H5dl1007-infected (TIC2) cells were
ith similar results. (D) Levels of viral DNA synthesis in HeLa and NLS.12 cells
of 10 μg of EcoRI digested total DNA prepared at 24 hpi. The C fragment from
Fig. 5. Mre11 is required for the formation ofMdc1 foci in response to E4mutant
infections. HeLa cells were transfected with control siRNA or Mre11 siRNA
prior to infection with H5dl1007 at 3 FFU/cell for 24 h. (A) Immunofluorescence
staining was performed to analyze the distribution of Mre11 and Mdc1. Panels a
to f show Mre11 and Mdc1 distribution in untransfected HeLa cells that were
either uninfected (a–c) or infected with H5dl1007 (d–f ). Panels g to l show
Mre11 and Mdc1 distribution in Mre11 siRNA transfected cells that were either
uninfected (g–i) or infected with H5dl1007 ( j–l). Bar 10 μm. Immunostained
cells from the time course were scored blind for Mdc1 foci formation in the
presence and absence ofMre11. The graph presented in (B) shows the percentage
of cells with Mdc1 foci in uninfected and infected cells prepared at the times
indicated, that were untransfected (black bars) or transfected (white bars) with
Mre11 siRNA.
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bind viral DNA rescues E4 mutant replication
Our earlier work showed that Mre11 interferes with E4
mutant DNA replication (Mathew and Bridge, 2007). Our
results with NLS.12 cells indicate that in the absence of Nbs1,
Mre11 does not efficiently associate with viral replication
centers or bind viral DNA even when it is directed to the
nucleus with an independent NLS. We next determined if the
inability of Mre11 to physically associate with viral genomes in
NLS.12 cells affects E4 mutant DNA replication. H5dl1007
infected NLS.12 cells have larger DNA replication centers than
those present in HeLa cells (Fig. 4A, compare h with q).
Southern blotting (Fig. 4D) shows that H5dl1007 DNA levels
were significantly increased in NLS.12 cells to within 2 fold of
Ad5. The 50- to 70-fold defect in E4 mutant DNA accumulation
seen in HeLa cells, is substantially rescued in NLS.12 cells
(Fig. 4D), indicating that the failure of Mre11 to associate with
the E4 mutant DNA replication centers and bind viral DNA in
NLS.12 cells (Figs. 4A and C) correlates with dramatically
improved DNA replication.
Mre11 is required for the formation of Mdc1 foci in response to
E4 mutant infections
Mdc1 accumulates in foci in response to IR induced damage
as well as following Ad infection. In IR induced damage, Mdc1
is required to sustain MRN foci formation at sites of DNA
damage (Goldberg et al., 2003). Although Ad infections induce
the accumulation of Mdc1 in early foci that correspond to viral
E2-72kDa-containing centers, we have found that the Mdc1
protein is not necessary for the accumulation of the Mre11
protein to these same foci (Mathew and Bridge, 2007). The
MRN complex has been implicated as a sensor of DNA damage
events that signal the activation of early response proteins such
as ATM and γH2AX, both of which potentially act upstream of
Mdc1 in the damage cascade (Stewart et al., 2003; Lou et al.,
2006). We were therefore interested in understanding if Mdc1
accumulation in foci in Ad infections was dependent on the
presence of Mre11. HeLa cells were either treated or not treated
with siRNA specific for Mre11, and then infected with
H5dl1007 at 3 FFU/cell. The results are shown in Fig. 5.
Control experiments were performed to ensure that the siRNA
used specifically knocked down Mre11 (Mathew and Bridge,
2007; data not shown). Immunofluorescence staining for Mre11
and Mdc1 was performed and representative results from a 6-h
time point are shown in Fig. 5A. We see that in the presence of
Mre11, E4 mutant infection results in Mdc1 accumulation in
distinct foci. However when Mre11 is knocked down in these
cells, there is a reduction in the number of cells with Mdc1 foci
in E4 mutant infections. To quantify this observation, cells were
scored blind to assess early Mdc1 foci formation in the presence
and absence of Mre11 (Fig. 5B). In untreated infected cells, we
see an increase in the number of cells that show Mdc1 foci from
2 to 6 hpi. However, when Mre11 is knocked down by its
specific siRNA, there is a significant decrease in the number of
infected cells that show distinct Mdc1 foci relative to theuntreated cells, indicating that Mre11 is important for formation
of early Mdc1 foci in E4 mutant infection.
Mdc1 binds to E4 mutant viral DNA
We see Mdc1 in foci corresponding to early replication foci
in response to E4 mutant infections and this process depends on
the presence of Mre11. This suggests that Mdc1 may be
aggregating in regions where the incoming viral genomes are
located. Mdc1 is not known to directly bind DNA; however, it is
present in protein complexes containing γH2AX that tightly
associate with damaged DNA (Stewart et al., 2003; Lou et al.,
2006). We performed chIP experiments as described in Fig. 1 to
determine if Mdc1 was physically interacting with viral
genomes. Chromatin immunoprecipitation with Abs against
Mdc1 and E2-72kDa was carried out on uninfected and E4
mutant infected samples prepared at 6 hpi and the results are
shown in Fig. 6. As expected, in both UI and E4 mutant infected
samples immunoprecipitation with Mdc1 Ab pulled down a
protein identified as Mdc1 in Western analysis (Fig. 6A, top
panel). Positive control experiments with viral E2-72kDa
specific antibodies also showed pull down of the viral E2-
72kDa protein in E4 mutant infected cells (Fig. 6A, bottom
Fig. 6. Mdc1 binds to E4 mutant viral DNA. HeLa cells were infected with
H5dl1007 at 30 FFU/cell for 6 h and processed for chIP as described in Fig. 1.
(A) Western blotting was performed to confirm immunoprecipitation of Mdc1
and E2-72kDa and representative blots are shown. Lanes from samples that were
immunoprecipitated with specific Ab or mock immunoprecipitated are labeled
(+) and (−), respectively. (B) PCR amplification using primers specific to the
E1b region was performed on uninfected (UI) and H5dl1007 (1007) infected
samples immunoprecipitated with Mdc1 or E2-72kDa Abs (+) or mock
immunoprecipitated in parallel (−). PCR products were analyzed as described in
Fig. 1. Total input chromatin (TIC) samples were included to indicate input
DNA levels in uninfected (TIC1) and H5dl1007 (TIC2) infected cells. The
Mdc1 chIP experiment was performed 3 times with similar results.
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amplified using viral specific primers corresponding to E1b,
and yielded a DNA fragment of the expected size (Fig. 6B). We
do not see a similar band in chromatin immunoprecipitated from
uninfected cells, or from samples that were mock immunopre-
cipitated in the absence of Ab. Control experiments using viral
E2-72kDa Ab showed a similar amplification of viral DNA
using the same primers (Fig. 6B). We have also found that
immunoprecipitation with PI3K Ab does not pull down E4
mutant DNA in parallel experiments (data not shown). Our
results indicate that cellular Mdc1 is bound to E4 mutant viral
DNA at early times after infection and suggest that Mdc1 may
be bound to viral DNA when it is redistributed to foci.
Discussion
The MRN complex is redistributed to foci that co-localize
with E2-72kDa in E4 mutant DNA replication centers (Stracker
et al., 2002). We have performed a time course with H5dl1007
and find that Mre11 foci are tightly associated with viral DNA
replication centers until around 12–15 hpi, after which the
localization of Mre11 becomes peripheral to the E2-72kDa
containing centers. This change in the localization of Mre11 is
accompanied by changes in the physical binding of Mre11 to E4
mutant DNA (Fig. 1). Mre11 binds E4 mutant DNA at 12 hpi.
Interestingly, later in the infection when Mre11 is no longer
tightly co-localized with the E2-72kDa centers, it also fails to
bind E4 mutant DNA in chIP assays. Although the reason for
this is as yet unclear, it could reflect a change in the efficiency of
Mre11 binding to viral DNA late in the infection. As viral
replication proteins accumulate they could out-compete Mre11
for efficient binding to viral DNA. Alternatively, the loss of
binding at late times in infection could reflect an end point in the
cellular response to the viral DNA damage signal, where theproteins are de-activated and return a diffuse nuclear distribu-
tion once they have finished “repairing” viral DNA to form
concatemers.
All three members of the MRN complex contribute to the
functioning of the complex (Luo et al., 1999; Yamaguchi-Iwai
et al., 1999; Zhu et al., 2001; reviewed in Assenmacher and
Hopfner, 2004). Mre11 is a DNA binding protein with exo- and
endonuclease activity and is an essential component of the DNA
DSB repair machinery (Trujillo et al., 1998; Paull and Gellert,
1998). Rad50 is required for the stable binding of Mre11 to
DNA (Connelly et al., 2003; de Jager et al., 2002; Paull and
Gellert, 1999; Trujillo and Sung, 2001) and provides the energy
needed for the enzymatic activities of Mre11 (Paull and Gellert,
2000). The Nbs1 component is essential for proper localization
of the MRN complex to the nucleus and its association with
damaged DNA (Desai-Mehta et al., 2001; Cerosaletti et al.,
2006). RNAi mediated knockdown of Mre11 (Mathew and
Bridge, 2007) and either Rad50 or Nbs1 (Figs. 2 and 3)
dramatically rescues E4 mutant DNA levels, suggesting that all
the members of the MRN complex are important for inhibiting
E4 mutant DNA replication. However, Rad50 RNAi affects the
stability of Mre11 while Nbs1 RNAi mis-localizes Mre11 in
the cytoplasm. Therefore these results do not determine if the
primary role of Nbs1 and Rad50 in inhibiting E4 mutant DNA
synthesis is through their effect on Mre11, or due to inde-
pendent functions.
Cerosaletti et al. (2006), established a simian virus 40
(SV40) transformed cell line using NBS fibroblasts from a
patient homozygous for the 657del5 mutation (Kraakman-van
der Zwet et al., 2003), engineered to express an Mre11 gene
with an artificial C-terminal nuclear localization signal (NLS)
sequence. These cells have a defective Nbs1 protein but Mre11
is still able to localize to the nucleus where it exists in a complex
with Rad50. IR treatment of these cells does not induce foci
formation or activation of the ATM response pathway,
suggesting a critical role for Nbs1 in the cellular response to
DNA damage independent of its ability to translocate Mre11 to
the nucleus (Cerosaletti et al., 2006). This experimental system
provides us with a unique opportunity to analyze the role of
Nbs1 in E4 mutant DNA replication in cells where Mre11 is
independently directed to the nucleus. The distinct Mre11 foci
seen in E4 mutant infected HeLa cells are not observed in the
NLS.12 cells that lack Nbs1 but have Mre11 localized in the
nucleus (Fig. 4). Interestingly, we cannot detect Mre11 binding
to viral DNA in NLS.12 cells in chIP assays, and the E4 mutant
DNA replication defect is alleviated (Fig. 4). These observa-
tions suggest that the physical binding of Mre11 to E4 mutant
viral DNA is dependent on Nbs1 and is important for the ability
of the MRN complex to interfere in E4 mutant DNA replication.
Nbs1 is not thought to bind DNA directly (reviewed in Zhou
et al., 2006), and in the absence of Mre11, neither Rad50 nor
Nbs1 is able to interfere with E4 mutant DNA replication
(Mathew and Bridge, 2007). Nbs1 binds to γH2AX and recruits
Mre11 and Rad50 to the proximity of IR induced DNA damage
(Tauchi et al., 2001). It is possible that it plays a similar role in
E4 mutant infections by loading Mre11 onto viral DNA to
perform repair functions.
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for the stability of MRN foci in IR induced damage (Goldberg
et al., 2003; Mochan et al., 2003). However, Mdc1 knockdown
does not affect Mre11 localization to E4 mutant replication foci
(Mathew and Bridge, 2007). Conversely, we find that Mre11 is
required for recruiting Mdc1 to E4 mutant replication foci
(Fig. 6). This suggests that Mre11 functions upstream of Mdc1
in the cellular response to E4 mutant infection, consistent with
the idea that Mre11 is a sensor of DNA damage (Carson et al.,
2003; reviewed by Petrini and Stracker, 2003). We find that
Mdc1 is physically bound to E4 mutant viral DNA (Fig. 6), but
since RNAi mediated knockdown of Mdc1 does not rescue E4
mutant DNA replication (Mathew and Bridge, 2007), the
significance of this interaction is not clear. It is possible that
Mre11 still binds to E4 mutant DNA in the absence of Mdc1,
and that this is sufficient to inhibit viral DNA replication. The
observation that Mre11 localization to E4 mutant DNA
replication foci does not require Mdc1 (Mathew and Bridge,
2007) supports this suggestion. Alternatively, RNAi knock-
down of Mdc1 may not sufficiently reduce levels of the protein
to affect Mre11 localization and E4 mutant DNA replication.
Although we have not identified a direct role for Mdc1 in
regulating E4 mutant DNA replication, it could nevertheless be
important for recruiting additional factors to E4 mutant
replication foci. DNA PK and Rad51 are essential components
of the NHEJ and HR pathways of DSBR, respectively, and are
known to interact with Mdc1 (Lou et al., 2004; Zhang et al.,
2005). The interaction of Mdc1 with viral DNA could also be
important for amplifying DNA damage responses initiated by
Ad infection. The ability of Mdc1 to simultaneously bind
γH2AX and ATM may facilitate ATM-dependent phosphoryla-
tion of H2AX and other DNA damage response proteins at sites
of DNA damage (Lou et al., 2006, reviewed in Kim et al.,
2006).
How does the MRN complex interfere in E4 mutant DNA
replication? Our data suggests that Nbs1 is important for
recruiting Mre11 to viral DNA. Mre11 could then potentially
interfere with viral DNA replication by physically hindering
DNA replication proteins from accessing viral DNA termini.
Alternatively or additionally, physical binding could be
necessary for the nuclease activity of Mre11, to destroy DNA
ends that contain the viral origin of replication. In this scenario,
the binding of Mre11 to viral DNAwould be a pre-requisite for
directing its enzymatic activity to viral DNA. In conclusion, our
results indicate that Mre11 binds E4 mutant viral DNA in an
Nbs1-dependent manner and in so doing, interferes with viral
DNA replication. Mre11 is also important for re-localization of
Mdc1 in response to E4 mutant infection, which is consistent
with its potential role as a sensor of DNA damage within cells.
Materials and methods
Cells and viruses
HeLa and E4 mutant-complementing W162 (Weinberg and
Ketner, 1983) monolayer cell cultures were maintained in
Dulbecco's Modified Eagle Medium (DMEM) supplementedwith 10% fetal bovine serum (FBS), 2 mM L-glutamine, 10 U/
mL penicillin and 10 μg/mL streptomycin. NBS-ILB1 cells
stably transfected with pLXIN retroviral vector alone or pLXIN
Mre11-NLS (NLS.12) were provided by K. Cerosaletti and P.
Concannon (Cerosaletti et al., 2006), and were maintained in
DMEM with 15% FBS, 500 μg/mL G418 (Invitrogen), 10 U/
mL penicillin and 10 μg/mL streptomycin. Ad5 and E4 mutant
H5dl1007 (Bridge and Ketner, 1989) were propagated on HeLa
and W162 cells, respectively. Their titers were determined in
W162 cells and expressed as fluorescent focus forming units
(FFU)/mL (Philipson, 1961). Cells were infected at a multi-
plicity of infection (MOI) of 3 or 30 FFU cell. E4 mutant
H5dl1007 carries a deletion that extends from the SmaI site in
E4 ORF1 to map unit 93.3 in the middle of ORF6. This mutant
lacks ORFs 2, 3, 3/4, and 4, deletes the N-terminus of ORFs 6
and 6/7, and deletes the C-terminus of ORF 1 (Bridge and
Ketner, 1989).
Immunofluorescence analysis
Infected and uninfected HeLa cells were seeded on cover
slips in 35mmdishes and fixed as described previously (Mathew
and Bridge, 2007). Cells on cover slips were fixed and stained
for immunofluorescence as described (Aspegren et al., 1998)
using the following primary antibodies: rabbit polyclonal anti-
Rad50 (Genetex), rabbit polyclonal anti-Nbs1 (Cell signaling),
goat polyclonal anti-Mre11 (Santa Cruz Biotechnology), and
rabbit polyclonal anti-Mdc1 (Bethyl Labs), at dilutions recom-
mended by the manufacturers. Rabbit polyclonal anti-72kDa (T.
Linné) was used at a 1:2000 dilution. Secondary antibodies
included Donkey anti-goat and anti-rabbit Alexafluor tagged
antibodies.
Microscopy
Images of cells were visualized and scored by conventional
fluorescence microscopy with a Nikon eclipse E-400 micro-
scope using a 100× objective. Images were obtained and
recorded using a SPOT-2 charge-coupled device and capture
software provided by the manufacturer (Diagnostic Instruments
Inc.). Confocal microscopy (Figs. 1 and 4) was performed with
an Olympus FV500 Fluoview using a 100× objective. Cells
labeled with a single fluorochrome (either Alexa 488/FITC or
Alexa 594/TR) were checked in both optical channels for cross
talk. No leakage of signal was observed between the two
channels. The images were assembled using Adobe photoshop
6.0/7.0 software.
Western blotting analysis
Infected or uninfected HeLa cells were processed for
Western blotting as described previously (Mathew and Bridge,
2007). Equal amounts of total protein were subjected to sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) analysis using 8% polyacrylamide gels. Proteins were
transferred to enhanced chemiluminescence (ECL) nitrocellu-
lose (Amersham Pharmacia) overnight and the membranes were
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Goat polyclonal Ab against Mre11 (Santa Cruz Biotechnology)
was used at a dilution of 1:250. Rabbit polyclonal Ab against
Mdc1 (Bethyl Laboratories) was diluted to 1:2500 for use.
Rabbit polyclonal Ab against Rad50 (Genetex) or Nbs1 (Cell
Signaling) was used at a dilution of 1:500. The mouse
monoclonal Ab against E2-72kDa (A. Levine) was diluted
1:100 for use. Protein blots were incubated with 1:1500 dilution
of horseradish peroxidase conjugated anti-goat (Santa Cruz
Biotechnology), anti-mouse or anti-rabbit IgG secondary
antibodies in 5% nonfat dry milk. Detection of proteins was
performed by incubating blots with ECL reagent and subse-
quently exposing them to ECL hyperfilm (Amersham). For
phosphorimaging analysis of proteins, a 1:2000 dilution of
alkaline phosphatase conjugated goat anti-rabbit IgG secondary
Ab (Sigma Aldrich) was used with enhanced chemifluorescence
(ECF) substrate (Amersham) and detected on a STORM 860
phosphorimager (Molecular Dynamics). Images were analyzed
using ImageQuant® 5.2 (Molecular Dynamics) software to
quantify the amount of protein.
Viral DNA analysis
Isolation of total DNA was performed from infected and
uninfected cells as described previously (Bridge and Ketner,
1989). 15 μg of total DNA from each sample was digested with
EcoRI and electrophoresed through a 1% agarose gel. DNAwas
transferred to Hybond-N nylon membrane (GE Healthcare/
Amersham) according to manufacturer's specifications, and
used for Southern blotting. A 32P-labeled probe was synthesized
from Ad5 genomic DNA using the multiprime DNA labeling
system (GE Healthcare/Amersham). Hybridization with
5×106 cpm/mL probe was performed at 65 °C for 20 h as
described (Sambrook et al., 1989). Levels of viral DNA were
quantified by phosphorimaging analysis of the Ad EcoRI C
fragment. Scanned images were analyzed using ImageQuant
5.2® (Molecular Dynamics) software to quantify the amount of
DNA.
RNAi analysis
HeLa cells seeded onto 35 mm tissue culture dishes at 50%
confluency were transfected with siRNA according to manufac-
turer's specifications (Dharmacon Technologies) at 200 pmol/
plate. siRNA against GAPD (positive control) (siCONTROL
Human GAPD Duplex D-001140-01-05) and non-targeting
scrambled siRNA (negative control) (siCONTROL non-targeting
siRNA pool D-001206-13-05) and a lipofection reagent (D1)
control were also included as controls for the experiments.
siRNA pools specific to human Rad50 (siGENOME smart pool
M-005232-01) or Nbs1 (siGENOME smart pool M-009641-01)
were used to knockdown the expression of these proteins. Levels
of the Rad50 or Nbs1 protein after siRNA transfection were
analyzed usingWestern blotting and immunofluorescence. HeLa
cells were cultured with siRNA for a minimum of 96 h before
infecting with Ad5 or H5dl1007 viruses for an additional 24 h.
Viral DNA analysis was then performed as described above.Chromatin immunoprecipitation (chIP)
ChIP experiments were performed using a variation of the
methods described in Ostapchuk et al. (2005) and Rosenke et al.
(2006). Briefly, 4–5×108 cells were infected for various times.
Cell monolayers in 10 cm disheswere incubatedwith 4mL of 1%
formaldehyde in DMEM lacking fetal bovine serum for 10 min.
Following this 125 mM glycine was added and incubated for
5 min to stop the formaldehyde treatment. The cells were washed
with ice-cold PBS twice, scraped into PBS supplemented with
a cocktail of protease inhibitors (0.1 μM PMSF, 20 μg/mL
Leupeptin and 20 μg/mL Aprotinin) and centrifuged for 4 min at
1000×g at 4 °C. The cells were lysed in SDS lysis buffer (50 mM
Tris–HCl [pH 8.0], 10 mM EDTA, 1% SDS) and then sonicated
8× for 15 s. Samples were clarified by centrifugation, and pre-
cleared by incubating with Gammabind sepharose (Amersham
Pharmacia) followed by centrifugation to remove proteins bound
non-specifically to the sepharose. The supernatants were then
used for immunoprecipitation with the following antibodies: goat
polyclonal anti-Mre11 (4 μg) (Santa Cruz biotechnology), mouse
monoclonal anti-PI3K (4 μg) (Santa Cruz Biotechnology),
mouse monoclonal anti-E2-72kDa (1:50 dilution) (A. Levine)
or rabbit polyclonal anti-Mdc1 (2 μg) (Bethyl Labs) using
manufacturer's specifications. Samples were incubated over-
night with the specific antibodies at 4 °C with gentle rotation.
Gammabind was added and the samples were incubated for 1 h at
4 °C. Washes were performed as described in Ostapchuk et al.
(2005). The samples were eluted by incubating with freshly
prepared elution buffer (50 mM sodium deoxycholate, 1% SDS)
for 15 min at room temperature with rotation. The gammabind
was removed by centrifugation and supernatants were collected.
The elution step was performed two more times. Formaldehyde
crosslinks were reversed by adding 150mMNaCl and incubating
the samples overnight at 65 °C. Proteinase K digestion was
performed at 45 °C for 1 h, followed by two phenol-chloroform
extraction steps and precipitation with ethanol. The precipitated
DNA was resuspended in nuclease free water and used in PCR
reactions with primers (E1b forward — 5′ taatgagctt-
gatctgctggcgc 3′; E1b reverse — 5′ accatgttatgcttaatcacagc 3′)
specific to the Ad E1b region.
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